Current role
Laura Clague
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Laura Clague
Standard Biotools Inc. reported in an 8-K filed January 5, 2024 that Laura Clague resigned as director, effective January 5, 2024.
“On January 5, 2024, in connection with the consummation of the Merger and pursuant to the Merger Agreement, Carlos Paya, M.D., Ph.D., Laura Clague and Martin Madaus, Ph.D. resigned from Standard BioTools' board of directors (the "Standard BioTools Board") and ceased serving on the Standard BioTools Board and any and all committees thereof.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Standard Biotools Inc. (LAB)
SEC 8-K
Current2020-05-07–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Standard Biotools Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Josh Bilenker CEO
- Dr. Michael Egholm CEO
- Michael Egholm CEO, Board Member
- Carlos Paya Chairman
- Tom Carey Chairman, Board Member
- Alex Kim CFO, COO
- Jeffrey G. Black CFO
- Spencer Smith CFO
- Hanjoon Alex Kim COO
- Shane Bowen CTO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.